on 01 Aug 2023
Last Applicant/ Owned by
Paasheuvelweg 25
Amsterdam
NL
1105BP
Serial Number
90779890 filed on 17th Jun 2021
Registration Number
7123793 registered on 01st Aug 2023
Correspondent Address
Julianne Abelman
Filing Basis
1. intent to use
Disclaimer
NO DATA
Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, Read More
Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics
Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing, namely, reagents for medical use; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases
No 90779890
No Service Mark
No 115710.0072.
Yes
No
No
Yes
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 01st Aug 2023 | REGISTERED-PRINCIPAL REGISTER |
| 01st Aug 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 26th Jun 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 26th Jun 2023 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| 01st May 2023 | TEAS DELETE 1(B) BASIS RECEIVED |
| 01st May 2023 | NOTICE OF ALLOWANCE CANCELLED |
| 25th Apr 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 28th Feb 2023 | PUBLISHED FOR OPPOSITION |
| 28th Feb 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Feb 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
